Entelos Signs Johnson & Johnson as First Partner in Simulation-Based Diabetes Research Forum | GenomeWeb

Entelos said last week that Johnson & Johnson Pharmaceutical Research and Development had agreed to become the first member in the Diabetes Research Forum Entelos formed in partnership with the American Diabetes Association in March.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.